相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer
Melissa A. Reimers et al.
EUROPEAN UROLOGY (2020)
Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab
Anna Minchom et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
CDK12-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade
Michael T. Schweizer et al.
JCO PRECISION ONCOLOGY (2020)
CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors
Emmanuel S. Antonarakis et al.
JCO PRECISION ONCOLOGY (2020)
Pan-Cancer Analysis of CDK12 Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype
Ethan S. Sokol et al.
ONCOLOGIST (2019)
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Yi-Mi Wu et al.
CELL (2018)
Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer
Raghav Sundar et al.
CLINICAL COLORECTAL CANCER (2018)
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia et al.
NATURE GENETICS (2018)
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
Daniel Nava Rodrigues et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Non-conventional Inhibitory CD4+Foxp3-PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity (vol 33, pg 1017, 2018)
Roberta Zappasodi et al.
CANCER CELL (2018)
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers
Pasquale Rescigno et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser et al.
NATURE (2017)
CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion
Jerry F. Tien et al.
NUCLEIC ACIDS RESEARCH (2017)
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
Shona Hendry et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters
M. Linch et al.
ANNALS OF ONCOLOGY (2017)
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research
Shona Hendry et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
Tristan A. Barnes et al.
BRITISH JOURNAL OF CANCER (2017)
Cdk12 is essential for embryonic development and the maintenance of genomic stability
H-C Juan et al.
CELL DEATH AND DIFFERENTIATION (2016)
Role and therapeutic potential of CDK12 in human cancers
Rosaria Chila et al.
CANCER TREATMENT REVIEWS (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex
Kingsley M. Ekumi et al.
NUCLEIC ACIDS RESEARCH (2015)
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS
Yawei Liu et al.
NATURE MEDICINE (2014)
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
Nicola Gagliani et al.
NATURE MEDICINE (2013)
Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase II
S. -W. Grace Cheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Consensus development of a histopathological classification system for chronic prostatic inflammation
JC Nickel et al.
BJU INTERNATIONAL (2001)
分享论文
